Alexander D R, Graves J D, Lucas S C, Cantrell D A, Crumpton M J
Cell Surface Biochemistry Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, U.K.
Biochem J. 1990 Jun 1;268(2):303-8. doi: 10.1042/bj2680303.
Activation of protein kinase C (PKC) in human T lymphocytes is an immediate consequence of mitogenic signalling via the antigen-receptor complex and CD2 antigen. In order to investigate further the signal-transduction pathways which result in PKC activation, we have established a novel PKC assay system using streptolysin-O-permeabilized T cells. Known peptide substrates of PKC were introduced into permeabilized cells in the presence of [gamma-32P]ATP, 3 mM-Mg2+ and 150 nM free Ca2+. The peptide found to have the lowest background phosphorylation had the sequence Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys (peptide GS), and the phosphorylation of the peptide was increased up to 6-fold by direct activation of PKC with phorbol 12,13-dibutyrate. Induction of PKC activation with the UCHT1 antibody against the CD3 antigen, or with phytohaemagglutinin (PHA) or guanosine 5'-[gamma-thio]triphosphate (GTP[S]), increased peptide-GS phosphorylation by 2-3 fold. The specificity of PKC action on peptide GS was demonstrated by blocking increases in phosphorylation with a pseudosubstrate peptide PKC inhibitor. PKC activation by this technique could be detected within 1 min of adding external ligand. Dose-response curves revealed that PHA-induced production of inositol phosphates correlated closely with PKC activities, whereas only a partial correlation between these parameters was observed with GTP[S]. Our data are consistent with the presence of more than one G-protein-mediated pathway of PKC regulation in T cells. The quantitative PKC assay system described is both simple and reproducible, and its potential application to a wide range of cell types should prove useful in further investigations of PKC activation mechanisms.
人T淋巴细胞中蛋白激酶C(PKC)的激活是经由抗原受体复合物和CD2抗原的促有丝分裂信号传导的直接结果。为了进一步研究导致PKC激活的信号转导途径,我们建立了一种使用链球菌溶血素-O通透化T细胞的新型PKC检测系统。在存在[γ-32P]ATP、3 mM Mg2+和150 nM游离Ca2+的情况下,将已知的PKC肽底物引入通透化细胞中。发现背景磷酸化最低的肽具有序列Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys(肽GS),并且通过用佛波醇12,13-二丁酸直接激活PKC,该肽的磷酸化增加了6倍。用抗CD3抗原的UCHT1抗体、或用植物血凝素(PHA)或鸟苷5'-[γ-硫代]三磷酸(GTP[S])诱导PKC激活,可使肽GS的磷酸化增加2至3倍。通过用假底物肽PKC抑制剂阻断磷酸化的增加,证明了PKC对肽GS作用的特异性。通过该技术在添加外部配体后1分钟内即可检测到PKC激活。剂量反应曲线显示,PHA诱导的肌醇磷酸产生与PKC活性密切相关,而在这些参数之间仅观察到GTP[S]的部分相关性。我们的数据与T细胞中存在多种G蛋白介导的PKC调节途径一致。所描述的定量PKC检测系统既简单又可重复,并且其在广泛细胞类型中的潜在应用应证明对进一步研究PKC激活机制有用。